• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TOTAL PSA IMMUNOASSAY; TOTAL,PROSTATE SPECIFIC ANTIGEN FOR DETECTION OF PROSTATE CANCER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TOTAL PSA IMMUNOASSAY; TOTAL,PROSTATE SPECIFIC ANTIGEN FOR DETECTION OF PROSTATE CANCER Back to Search Results
Catalog Number 04491734190
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/26/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The initial reporter stated they received discrepant results for two samples from the same patient tested with the elecsys free psa immunoassay and the elecsys total psa immunoassay on a cobas 8000 e 602 module.The free psa values were larger than the total psa values.The test results were reported outside of the laboratory to the patient.This medwatch will apply to the total psa assay.Please refer to the medwatch with the patient identifier (b)(6) for information related to the free psa assay.The first sample was tested twice using the free psa assay, resulting with values of 1.05 ng/ml and 1.03 ng/ml.This sample was tested twice using the total psa assay, resulting with values of 0.110 ng/ml and 0.094 ng/ml.The second sample was tested using the free psa assay on (b)(6) 2020, resulting with a value of 1.13 ng/ml.This sample was repeated using the free psa assay on (b)(6) 2020, resulting with a value of 1.12 ng/ml.This sample was tested using the total psa assay on (b)(6) 2020, resulting with a value of 0.096 ng/ml.This sample was repeated using the total psa assay on (b)(6) 2020, resulting with a value of 0.087 ng/ml.The serial number of the e 602 analyzer is (b)(4).
 
Manufacturer Narrative
A sample from the patient was provided for investigation and the results obtained by the customer could be reproduced.No evidence of an interfering substance was found in the sample.Further investigations determined there was evidence the sample contains a seldom psa-isoform that cannot be completely detected by the usage of the standard total psa assay.Per product labeling: "it is known that in rare cases psa isoforms do exist which may be measured differently by different psa tests.Findings of this kind have occasionally been reported for psa tests from various manufacturers." a general reagent issue could be excluded.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TOTAL PSA IMMUNOASSAY
Type of Device
TOTAL,PROSTATE SPECIFIC ANTIGEN FOR DETECTION OF PROSTATE CANCER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10546966
MDR Text Key207354327
Report Number1823260-2020-02285
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
PMA/PMN Number
P990056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 12/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04491734190
Device Lot Number409527
Was Device Available for Evaluation? Yes
Date Manufacturer Received08/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age63 YR
-
-